- Category
- Micro (2021-22)
- Udyam number
- UDYAM-RJ-17-0125908

Accuris Pharmaceutical Private Limited
About Accuris Pharmaceutical Private Limited
Data last updated:
Accuris Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33100RJ2021PTC076500. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.2 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Samit Seth and Archana Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 2 Gayatri Dham A – 412 Kalwar Road Kardhani, Jaipur, Rajasthan, India – 302012.
The company has about 12 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 4 filed against it; 4 cases are pending.
Accuris Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0125908). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Accuris Pharmaceutical
Contact details
Accuris Pharmaceutical Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF – 2 Gayatri Dham A – 412 Kalwar Road Kardhani, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Accuris Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Accuris Pharmaceutical are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Accuris Pharmaceutical Private Limited, buy the company report.
Financials of Accuris Pharmaceutical Private Limited
FY 2025 filings availableAccuris Pharmaceutical Private Limited reported revenue of ₹454 (down 100% YoY) for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Accuris Pharmaceutical Private Limited, buy the company report.
Board of directors of Accuris Pharmaceutical Private Limited
Accuris Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samit Seth | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Archana Sharma Also directs: Accuris Neuro Pharmaceuticals Private Limited | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Accuris Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swasthaayu Private Limited | ₹520 (FY 2023) | Pune, Maharashtra, India | ||||
| Throaton Pharmaceutical Private Limited | ₹501 (FY 2020) | New Delhi, Delhi, India | ||||
| Camorra Industries Private Limited | ₹500 (FY 2025) | -100.0% | Ankleshwar, Gujarat, India | |||
| Glands Health and Foods Private Limited | ₹500 (FY 2024) | -79.0% | Mumbai, Maharashtra, India | |||
| Im Inicio Projects Private Limited | ₹500 (FY 2025) | Gurugram, Haryana, India | ||||
| Accuris Pharmaceutical Private Limitedthis company | ₹454 (FY 2024) | -100.0% | Jaipur, Rajasthan, India | |||
| Vinecure Health Private Limited | ₹453 (FY 2023) | Faridabad, Haryana, India | ||||
| Aditya Color Works Private Limited | ₹450 (FY 2025) | -100.0% | Ahmedabad, Gujarat, India | |||
| Adhishthaanam Universe (OPC) Private Limited | ₹388 (FY 2021) | Ahmedabad, Gujarat, India | ||||
| Anish Colourchem Private Limited | ₹375 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Sreint Pharmaceuticals Private Limited | ₹375 (FY 2022) | Hyderabad, Telangana, India |
To see the full peer comparison of Accuris Pharmaceutical Private Limited, buy the company report.
Auditor
Accuris Pharmaceutical Private Limited is audited by JAIN KAMAL & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN KAMAL & CO | FY 2023 | 022088C |
Shareholding
The shareholding of Accuris Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Accuris Pharmaceutical Private Limited, buy the company report.
Legal cases
Accuris Pharmaceutical Private Limited has 4 court cases on record: 4 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 4 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
To see the full case history of Accuris Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Accuris Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Accuris Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Accuris Pharmaceutical Private Limited, buy the company report.
Recent activity
Accuris Pharmaceutical Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Vinita Shukla ceased to be Director on 21 Mar 2022.
Frequently asked questions
Accuris Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2021 (5+ years old) and is registered under CIN U33100RJ2021PTC076500.
Accuris Pharmaceutical has 2 current directors:
- Samit Seth - Director
- Archana Sharma - Director
The latest financial statements of Accuris Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
No. Accuris Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Accuris Pharmaceutical is U33100RJ2021PTC076500. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Accuris Pharmaceutical has 4 court cases on record: 4 filed against it. 4 are pending.
Accuris Pharmaceutical was incorporated on 17 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Accuris Pharmaceutical by revenue are Swasthaayu Private Limited, Throaton Pharmaceutical Private Limited, Camorra Industries Private Limited, Glands Health and Foods Private Limited, Im Inicio Projects Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vinita Shukla ceased to be Director on 21 Mar 2022. Archana Sharma was appointed as Director on 17 Aug 2021. Samit Seth was appointed as Director on 17 Aug 2021.
Yes, Accuris Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0125908).
The registered office of Accuris Pharmaceutical is at F – 2 Gayatri Dham A – 412 Kalwar Road Kardhani, Jaipur, Rajasthan, India – 302012.

